23-Dideoxycytidine 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0.0±2.2 mmHg at 25℃ |
| Water Solubility | Soluble |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.686 |
| B pt. | 415℃ at 760 mmHg |
| M pt. | 209℃ |
| Density | 1.57 g/cm3 |
Safety Information
| Hazard Statement(s) | H361-H351 |
| Precautionary Statement | P501-P202-P201-P280-P308 + P313-P405 |
| Symbol |
|
| Signal word | Warning |
| HS Code | 2934999090 |
| Flash point | 204.8℃ |
| Storage Temp. | ?20℃ |
| Packaging | Poly Bottle |
Description
Recommended products
N-(Tert-Butoxycarbonyl)-Trans-4-Hydroxy-L-Proline Methyl Ester 95.0%(GC)
Application
23-Dideoxycytidine is used as a DNA chain-terminating nucleotide for DNA sequencing methods based on the Sanger chain-termination method.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Zalcitabine (2-3-dideoxycytidine ddC) also called dideoxycytidine is a nucleoside analog reverse transcriptase inhibitor (NARTI) sold under the trade name Hivid. Zalcitabine was the third antiretroviral to be approved by the Food and Drug Administration (FDA) for the treatment of HIVAIDS. It is used as part of a combination regimen.
Documents
|
COA Not Available |
|
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |